Skip to content
10-Q

Quarterly Report

TETRALOGIC PHARMACEUTICALS CORP

0001558370-16-009260

← back to feed
Filed
Nov 3, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Oct 28, 2016 24.77M sh
Shares Diluted Q3 2016 · Sep 30, 2016 24.77M sh
Shares Diluted Q3 2016 · Sep 30, 2016 24.77M sh
Shares Diluted Q3 2016 · Sep 30, 2015 23.86M sh
Shares Diluted Q3 2016 · Sep 30, 2015 23.37M sh
Cash And Equivalents Q3 2016 · Sep 30, 2016 $5.89M
Cash And Equivalents Q3 2016 · Dec 31, 2015 $15.3M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $15.91M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $13.07M
Stockholders Equity Q3 2016 · Sep 30, 2016 −$30.94M
Stockholders Equity Q3 2016 · Dec 31, 2015 −$5.94M
Current Liabilities Q3 2016 · Sep 30, 2016 $13.33M
Current Liabilities Q3 2016 · Dec 31, 2015 $3.66M
Total Liabilities Q3 2016 · Sep 30, 2016 $73.73M
Total Liabilities Q3 2016 · Dec 31, 2015 $69.96M
Current Assets Q3 2016 · Sep 30, 2016 $6.37M
Current Assets Q3 2016 · Dec 31, 2015 $21.97M
Total Assets Q3 2016 · Sep 30, 2016 $42.79M
Total Assets Q3 2016 · Dec 31, 2015 $64.02M
Eps Diluted Q3 2016 · Sep 30, 2016 −$0.35
Eps Diluted Q3 2016 · Sep 30, 2016 −$1.07
Eps Diluted Q3 2016 · Sep 30, 2015 −$0.46
Eps Diluted Q3 2016 · Sep 30, 2015 −$1.52
Eps Basic Q3 2016 · Sep 30, 2016 −$0.35
Eps Basic Q3 2016 · Sep 30, 2016 −$1.07
Eps Basic Q3 2016 · Sep 30, 2015 −$0.46
Eps Basic Q3 2016 · Sep 30, 2015 −$1.52
Sga Expense Q3 2016 · Sep 30, 2016 $1.47M
Sga Expense Q3 2016 · Sep 30, 2016 $6.83M
Sga Expense Q3 2016 · Sep 30, 2015 $2.52M
Sga Expense Q3 2016 · Sep 30, 2015 $8.54M
Net Income Q3 2016 · Sep 30, 2016 −$8.63M
Net Income Q3 2016 · Sep 30, 2016 −$26.45M
Net Income Q3 2016 · Sep 30, 2015 −$10.9M
Net Income Q3 2016 · Sep 30, 2015 −$35.45M
Operating Income Q3 2016 · Sep 30, 2016 −$9.22M
Operating Income Q3 2016 · Sep 30, 2016 −$23.58M
Operating Income Q3 2016 · Sep 30, 2015 −$9.74M
Operating Income Q3 2016 · Sep 30, 2015 −$32.05M
Revenue Q3 2016 · Sep 30, 2016 $0
Capex Q3 2016 · Sep 30, 2015 $76.67K